Complete Restriction of Fluoroquinolone Use to Control an Outbreak of Clostridium difficile Infection at a Community Hospital

被引:69
作者
Kallen, Alexander J. [1 ,2 ]
Thompson, Angela [1 ]
Ristaino, Polly [4 ]
Chapman, Leigh [4 ]
Nicholson, Ainsley [1 ]
Sim, Bich-Thuy [1 ]
Lessa, Fernanda [1 ,2 ]
Sharapov, Umid [2 ,3 ]
Fadden, Elaine [4 ]
Boehler, Richard [4 ]
Gould, Carolyn [1 ]
Limbago, Brandi [1 ]
Blythe, David [5 ]
McDonald, L. Clifford [1 ]
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Preparedness Detect & Control Infect Dis, Div Healthcare Qual Promot, Atlanta, GA USA
[2] Ctr Dis Control & Prevent, Off Workforce & Career Dev, Epidem Intelligence Serv, Atlanta, GA USA
[3] Ctr Dis Control & Prevent, Natl Ctr Zoonot Vector Borne & Enter Dis, Div Foodborne Bacterial & Mycot Dis, Atlanta, GA USA
[4] St Joseph Med Ctr, Towson, MD USA
[5] Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA
关键词
NORTH-AMERICA; RISK-FACTOR; DIARRHEA; DISEASE; EPIDEMIC; STRAIN; CLINDAMYCIN; TOXIN; ASSOCIATION; EMERGENCE;
D O I
10.1086/595694
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVE. To review the effect of interventions, including a complete restriction in the use of fluoroquinolones (FQs), used to control an outbreak of hospital-onset Clostridium difficile infection (HO-CDI) caused primarily by the epidemic North American pulsed-field gel electrophoresis type 1 strain. DESIGN. Retrospective cohort and case-control study of all episodes of HO-CDI both before and after 2 interventions. SETTING. Community hospital; January 1, 2005, through March 31, 2007. INTERVENTIONS. Complete, 5-month, facility-wide restriction of fluoroquinolone use, during which a change in the environmental-services contractor occurred. RESULTS. During a 27-month period, 319 episodes of HO-CDI occurred. The hospital-wide mean defined daily doses of antimicrobials decreased 22% after restricting FQ use, primarily because of a 66% decrease in the use of FQs. The interventions were also associated with a significant change in the HO-CDI incidence trends and with an absolute decrease of 22% in HO-CDI cases caused by the epidemic strain (from 66% before the intervention period to 44% during and after the intervention period; P = .02). Univariate analysis revealed that case patients with HO-CDI due to the epidemic strain were more likely than control patients, who did not have diarrhea, to receive a FQ, whereas case patients with HO-CDI due to a nonepidemic strain were not. However, FQ use was not significantly associated with HO-CDI in multivariable analysis. CONCLUSIONS. An outbreak of epidemic-strain HO-CDI was controlled at a community hospital after an overall decrease in antimicrobial use, primarily because of a restriction of FQ use and a change in environmental-services contractors. The restriction of FQ use may be useful as an adjunct control measure in a healthcare facilities during outbreaks of epidemic-strain HO-CDI.
引用
收藏
页码:264 / 272
页数:9
相关论文
共 31 条
  • [1] Effect of fluoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic Clostridium difficile strains in the Cecal contents of mice
    Adams, Daniel A.
    Riggs, Michelle M.
    Donskey, Curtis J.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (08) : 2674 - 2678
  • [2] [Anonymous], DAT STAT CLOSTR DIFF
  • [3] BRILLER P, 2007, INFECT CONT HOSP EP, V28, P198
  • [4] Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years
    Carling, P
    Fung, T
    Killion, A
    Terrin, N
    Barza, M
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2003, 24 (09) : 699 - 706
  • [5] Clostridium difficile-associated disease in Oregon:: Increasing incidence and hospital-level risk factors
    Chandler, Rebecca E.
    Hedberg, Katrina
    Cieslak, Paul R.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (02) : 116 - 122
  • [6] Hospital-wide restriction of clindamycin:: Effect on the incidence of Clostridium difficile-associated diarrhea and cost
    Climo, MW
    Israel, DS
    Wong, ES
    Williams, D
    Coudron, P
    Markowitz, SM
    [J]. ANNALS OF INTERNAL MEDICINE, 1998, 128 (12) : 989 - +
  • [7] Clostridium difficile-associated disease in a setting of endemicity:: Identification of novel risk factors
    Dubberke, Erik R.
    Reske, Kimberly A.
    Yan, Yan
    Olsen, Margaret A.
    McDonald, L. Clifford
    Fraser, Victoria J.
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 45 (12) : 1543 - 1549
  • [8] Evaluation of Clostridium difficile -: Associated disease pressure as a risk factor for C difficile -: Associated disease
    Dubberke, Erik R.
    Reske, Kimberly A.
    Olsen, Margaret A.
    McMullen, Kathleen M.
    Mayfield, Jennie L.
    McDonald, L. Clifford
    Fraser, Victoria J.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (10) : 1092 - 1097
  • [9] Outbreak of Clostridium difficile infection in a long-term care facility:: Association with gatifloxacin use
    Gaynes, R
    Rimland, D
    Killum, E
    Lowery, HK
    Johnson, TM
    Killgore, G
    Tenover, FC
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 (05) : 640 - 645
  • [10] GERDING DN, 1995, INFECT CONT HOSP EP, V16, P459